Fiorino Gionata, Caprioli Flavio Andrea, Onali Sara, Macaluso Fabio Salvatore, Bezzio Cristina, Armelao Franco, Armuzzi Alessandro, Baldoni Monia, Bodini Giorgia, Castiglione Fabiana, Daperno Marco, Festa Stefano, Furfaro Federica, Gionchetti Paolo, Leone Salvatore, Luglio Gaetano, Milla Monica, Mocci Giammarco, Napolitano Daniele, Orlando Ambrogio, Previtali Enrica, Pugliese Daniela, Renna Sara, Rispo Antonio, Saibeni Simone, Sampietro Gianluca, Savarino Edoardo, Scaldaferri Franco, Spagnuolo Rocco, Variola Angela, Viola Anna, Viscido Angelo, Vitale Giovanna, Zaetta Debora, Zingone Fabiana, Colli Agostino, Fantini Massimo Claudio
IBD Unit, Department of Gastroenterology and Digestive Endoscopy, San Camillo-Forlanini Hospital, Rome, Italy.
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Dig Liver Dis. 2025 Jun;57(6):1135-1140. doi: 10.1016/j.dld.2025.03.010. Epub 2025 Apr 5.
Inflammatory bowel disease (IBD) poses significant clinical challenges due to its chronic, disabling nature. Despite established guidelines, care standards remain inconsistent globally. In 2020, the European Crohn's Colitis Organisation (ECCO) developed quality-of-care standards. The Italian Group for the Study of IBD (IG-IBD) aimed to adapt those recommendations to Italy.
A 42-member interdisciplinary panel used a Delphi consensus to evaluate and modify ECCO statements and levels of importance, incorporating patient representatives and regional experts. Those statements were revised, some missing statements were added, and a two-round voting session was held among participants. Agreement ≥80 % was needed to approve a statement.
From 101 ECCO statements, 112 tailored criteria were developed. In comparison to the ECCO statements, 80 were confirmed with the same level of importance, 9 were confirmed with different levels of importance, 9 points were merged in a broader statement, 3 points were dropped out during the two voting rounds, and 12 were added as new points.
The adapted standards provide a framework for standardizing IBD care in Italy. This model might help other countries in aligning with ECCO standards.
炎症性肠病（IBD）因其慢性、致残性的特点带来了重大的临床挑战。尽管已有既定指南，但全球范围内的护理标准仍不一致。2020年，欧洲克罗恩病和结肠炎组织（ECCO）制定了护理质量标准。意大利炎症性肠病研究小组（IG-IBD）旨在使这些建议适用于意大利。
一个由42名成员组成的跨学科小组采用德尔菲共识法来评估和修改ECCO声明及重要性水平，纳入了患者代表和地区专家。对这些声明进行了修订，添加了一些缺失的声明，并在参与者之间举行了两轮投票。声明获得≥80%的同意票方可获批。
从101条ECCO声明中，制定了112条量身定制的标准。与ECCO声明相比，80条以相同的重要性水平得到确认，9条以不同的重要性水平得到确认，9条合并为一条更宽泛的声明，3条在两轮投票中被淘汰，12条作为新内容被添加。
改编后的标准为意大利IBD护理的标准化提供了一个框架。该模式可能有助于其他国家与ECCO标准保持一致。
